Article

Bifurcated Lesions and Optical Coherence Tomography

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

  • Views: 702

  • Likes: 0

  • Downloads: 1

Average (ratings)
No ratings
Your rating

Abstract

Coronary artery bifurcation lesions constitute a complex subgroup that are encountered in 15–20 % of all percutaneous coronary interventions (PCI).1–5 Compared with simple lesions, bifurcations have been associated with lower procedural success rates, higher adverse event rates, longer procedures, and worse angiographic and clinical outcomes.1,3,5–12 The less favourable outcomes associated with bifurcation treatment compared with non-bifurcation lesions may in part result from the inability of current devices and techniques to adequately scaffold and preserve the side branch (SB) ostium, which is a common location of restenosis.1,3,5–13

Keywords

Bifurcation lesions, Side branch stenting, Side branch angioplasty, Optical coherence tomography (OCT), Coronary artery stenosis,

Received:

Accepted:

Citation: RadcliffeCardiology.com, April 2014

Support:The publication of this information was supported by St. Jude Medical.

Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

Stenting using drug-eluting stents (DES) is currently the default approach to bifurcation PCI, due to their superior angiographic and clinical outcomes as compared with bare metal stents (BMS). Refinement of the various techniques used (high-pressure stent deployment or post-dilatation, kissing balloon inflation), better selection of lesions to be treated with a two-stent technique, and deferral of treatment of SB ostial lesions with an angiographically suboptimal result after main branch (MB) stenting but functionally non-significant, have led to even better outcomes, narrowing the gap with non-bifurcation PCI.1,6,14–17 Bifurcation PCI with DES is associated with a higher stent thrombosis (ST).1,2,6,15–17 Contemporary randomised studies have shown that routine stenting of both branches offers no benefit over stenting of the MB only, with provisional stenting of the SB, making the provisional strategy the preferred approach.

Bifurcation Techniques
Provisional Stenting
This strategy consists of implanting a stent in the MB first, proceeding to SB stenting only if its appearance after MB stenting is considered suboptimal. Bifurcation lesions where the SB is suitable for stenting (expected diameter equal or greater than 2.25 mm) and has minimal disease (‘non-true’ bifurcation) or significant disease but confined to the ostium or extending <5 mm from the ostium (‘true’ bifurcation) are tackled with this strategy. Generally SB predilatation must be performed only if the lesion is very severe, angulated or highly calcified. Achievement of an optimal proximal MB stent expansion and apposition, using the proximal optimisation technique (POT), prevents the wire from passing outside the proximal MB stent during wire exchange. If the result in the SB is satisfactory,1,2,17–19 the procedure is complete. In case the result in the SB is suboptimal, rewire the SB and a final kissing inflation (FKI) can then be performed with moderate pressure in the SB. If the result in the SB is still suboptimal (>75 % residual stenosis and/or Thrombolysis in Myocardial Infarction [TIMI] flow <3, fractional flow reserve [FFR] <0.75, flow-limiting dissection, abrupt vessel closure) proceed with SB stenting (T-stent, T And Protrusion or culotte techniques).1,4,20–22

Two-stent Techniques
A two-stent strategy as intention-to-treat should be considered intrue bifurcations (Medina 1.1.1, 1.0.1 and 0.1.1)23–25 when a significant SB is involved (>2.5 mm, large amount of myocardium subtended, disease extending >5 mm from the ostium).14

Culotte, Crush and Simultaneous Kissing Stent
Culotte and crush techniques have been designed to provide complete scaffolding of the SB and the MB. These techniques are usually employed for a large SB (>2.5 mm) with relatively low take off angles. In the culotte technique, a first stent is deployed in one of thebranches, usually across the most angulated of the two, which most often is the SB. The second branch is then rewired through the strut of the first stent and dilated with a non-compliant balloon. The second stent is implanted followed by FKI.6,26

In contrast, using the crush technique, a stent is first positioned in the SB and retracted to protrude in the MB (>5 mm in the classical crush or 1–2 mm in mini-crush). The protruding portion of the SB stent is then crushed against the wall by deployment of the MB stent or dilatation with a noncompliant (NC) balloon. The procedure needs to be completed with the rewiring of the SB and FKI post-dilatation. This complex technique requires more steps than the culotte technique, and has more limitedanatomical applications, explaining why the crush technique is almost never used nowadays. Another technique for complex bifurcation treatment is the simultaneous kissing stent (SKS) technique. Both SB and MB stent are deployed either simultaneously or sequentially to form a double-barrel stent with a neocarina in the MB. Such a technique has the advantage of not requiring recrossing of the stent, but the SKS technique raises concerns over potential risk of stent thrombosis induced by the long double neocarina in the MB.

T-stenting and the T And Protrusion Technique
In the classical T-stenting technique, a stent is implanted in the SB up to the SB ostium. A second stent is then deployed in the MB and the procedure is completed by FKI. It is a popular approach for wide angle (>70°) T-shaped bifurcation because it provides coverage of the SB with minimal stent protrusion in the MB. A popular adaptation of the T-stenting that offers good strut coverage at the expense of a predictable increase of malapposition of the ostium is the T And Protrusion (TAP) technique. The SB stent is advanced and left with a minimal protrusion (1–2 mm) into the MB.

Dedicated Stents for Bifurcations
The ideal stent for bifurcations7,23,24,27 should be easy to use, intuitive and should simplify the procedure by shortening the procedural time and X-ray exposure, and decreasing the amount of contrast media. It should be safe, allow permanent SB access and have a high rate of device success with predictable successful ostial SB stenting. It should also provide an optimal long-term outcome with a low rate of restenosis and stent thrombosis. Many devices are already available or under clinical investigation.

Optical Coherence Tomography Guidance
Optical coherence tomography (OCT) is a high resolution intravascular imaging tool used to assess coronary lesions and evaluate the results of stenting. In bifurcated lesions, it is particularly helpful in guiding several steps.28 For example, immediate automated online detection of the lumen area after pullback will assist in the rapid assessment of the vessel morphology and minimum lumen area (Lightlab C7, St. Jude Medical, St. Paul, Minnesota, US). This may be particularly useful for guidance of interventions in bifurcations, where knowing the reference diameter of the vessel distal and proximal to the SB iscritical in correctly sizing the diameter and length both of the stent and post-dilatation balloon.

In addition, the recent development of OCT with online three-dimensional (3D) reconstruction allows the operator to obtain a 3D visualisation of the lesion and to plan a strategy accordingly. Initial experience of using 3D OCT reconstruction has revealed how 3D images may provide a unique tool for guidance during complex intervention in bifurcation, and potentially improve stenting results.29,30

SB ostium restenosis still remains the Achilles heel of bifurcation stenting. Opening the stent strut at the SB ostium is considered critical to avoid coverage with neointimal tissue and risk of stent thrombosis. Several parameters affect SB opening during bifurcation stenting, for example the platform design and the size of the balloon.31,32 To efficiently open a stent at the SB ostium, current recommendations suggest attempting to recross the wire through the most distal cell of the MB stent to achieve optimal scaffolding of the SB ostium and avoid leaving unopposed struts near the carina. It can, however, be difficult in practice to ensure that the SB has not been accessed through aproximal cell. Thus it becomes possible for the interventionist to check that crossing to the SB is satisfactory and one can further anticipate the result after balloon dilatation or implantation of a second stent and final kissing-balloon Inflation.30 Finally, OCT visualisation of the distal and proximal edges of the stent will rule out the presence of dissections, undetectable by angiography alone.29

Conclusions
Bifurcational PCI are complex procedures leading to high rates of malapposed struts. OCT is a high resolution intravascular imaging tool that allows accurate assessment during bifurcational stenting, guiding interventional cardiologists to better procedural results. Future generations of OCT equipment will include several technological advances that may further enhance the capabilities of this imaging method.

References

  1. Latib A, Colombo A, Bifurcation disease: what do we know, what should we do?, JACC Cardiovasc Interv, 2008;1(3):218–26.
  2. Hermiller JB, Contemporary bifurcation treatment strategies: the role of currently available slotted tube stents, Rev Cardiovasc Med, 2010;11 Suppl 1:S17–26.
  3. Stankovic G, Darremont O, Ferenc M, et al., Percutaneous coronary intervention for bifurcation lesions: 2008 consensus document from the fourth meeting of the European Bifurcation Club, EuroIntervention, 2009;5(1):39–49.
  4. Iakovou I, Ge L, Colombo A, Contemporary stent treatment of coronary bifurcations, J Am Coll Cardiol, 2005;46(8):1446–55.
  5. Sharma SK, Mare AM, Kini AS, Coronary bifurcation lesions, Minerva Cardioangiol, 2009;57(5):667–82.
  6. Iakovou I, Foin N, Andreou A, et al., New strategies in the treatment of coronary bifurcations, Herz, 2011;36(3):198–213.
  7. Lefévre T, Chevalier B, Louvard Y, Is there a need for dedicated bifurcation devices?, EuroIntervention, 2010;6 Suppl J:J123–9.
  8. Verheye S, Agostoni P, Dubois CL, et al., 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study, J Am Coll Cardiol, 2009;53(12):1031–9.
  9. Colombo A, Moses JW, Morice MC, et al., Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions, Circulation, 2004;109(10):1244–9.
  10. Brar SS, Gray WA, Dangas G, et al., Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials, EuroIntervention, 2009;5(4):475–84.
  11. Pendyala L, Jabara R, Hou D, et al., Review of percutaneous therapy for bifurcation lesions in the era of drug-eluting stents, Minerva Cardioangiol, 2008;56(1):89–105.
  12. Louvard Y, Lefévre T, Morice MC, Percutaneous coronary intervention for bifurcation coronary disease, Heart, 2004;90(6):713–22.
  13. Ge L, Tsagalou E, Iakovou I, et al., In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent, Am J Cardiol, 2005;95(6):757–60.
  14. Lindsay AC, Viceconte N, di Mario C, Optical coherence tomography: has its time come?, Heart, 2011;97(17):1361–2.
  15. Iakovou I, Mehran R, Dangas G, Thrombosis after implantation of drug-eluting stents, Hellenic J Cardiol, 2006;47(1):31–8.
  16. Iakovou I, Schmidt T, Bonizzoni E, et al., Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 2005;293(17):2126–30.
  17. Hildick-Smith D, Lassen JF, Albiero R, et al., Consensus from the 5th European Bifurcation Club meeting, EuroIntervention, 2010;6(1):34–8.
  18. Mangiacapra F, Di Serafino L, Barbato E, The role of fractional flow reserve to guide stent implantation, Minerva Cardioangiol, 2011;59(1):39–48.
  19. Colombo A, Bramucci E, Saccà S, et al., Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study, Circulation, 2009;119(1):71–8.
  20. Latib A, Colombo A, Sangiorgi GM, Bifurcation stenting: current strategies and new devices, Heart, 2009;95(6):495–504.
  21. Sheiban I, Omedé P, Biondi-Zoccai G, et al., Update on dedicated bifurcation stents, J Interv Cardiol, 2009;22(2):150–5.
  22. Melikian N, Airoldi F, di Mario C, Coronary bifurcation stenting. Current techniques, outcome and possible future developments, Minerva Cardioangiol, 2004;52(5):365–78.
  23. Nakazawa G, Yazdani SK, Finn AV, et al., Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation, J Am Coll Cardiol, 2010;55(16):1679–87.
  24. Medina A, Suárez de Lezo J, Pan M, [A new classification of coronary bifurcation lesions], Rev Esp Cardiol, 2006;59(2):183.
  25. Duraiswamy N, Schoephoerster RT, Moore JE Jr, Comparison of near-wall hemodynamic parameters in stented artery models, J Biomech Eng, 2009;131(6):061006.
  26. Viceconte N, Chan PH, Alegria-Barrero E, et al., Frequency domain optical coherence tomography for guidance of coronary stenting, Int J Cardiol, 2013;166(3):722–8.
  27. Meredith IT, Worthley S, Whitbourn R, et al., First-in-human experience with the Medtronic Bifurcation Stent System, EuroIntervention, 2011;7(6):662–9.
  28. Gutiérrez-Chico JL, Alegría-Barrero E, Teijeiro-Mestre R, et al., Optical coherence tomography: from research to practice, Eur Heart J Cardiovasc Imaging, 2012;13(5):370–84.
  29. Di Mario C, Iakovou I, van der Giessen WJ, et al., Optical coherence tomography for guidance in bifurcation lesion treatment, EuroIntervention, 2010;6 Suppl J:J99–06.
  30. Alegría-Barrero E, Foin N, Chan PH, et al., Choosing the right cell: guidance with three-dimensional optical coherence tomography of bifurcational stenting, Eur Heart J Cardiovasc Imaging, 2012;13 (5):443.
  31. Foin N, Viceconte N, Chan PH, et al., Jailed side branches: fate of unapposed struts studied with 3D frequency-domain optical coherence tomography, J Cardiovasc Med (Hagerstown), 2011;12(8):581–2.
  32. Foin N, Torii R, Mortier P, et al., Kissing balloon or sequential dilation of the side branch and main vessel for provisional stenting of bifurcations lessons from micro-computed tomography and computational simulations, JACC Cardiovasc Interv, 2012;5(1):47–56.